Abstract Details

Title Amyloid PET Screening for Enrollment into Alzheimer's Disease Clinical Trials: Initial Experience in a Phase 1b Clinical Trial

Topic Aging, Dementia, and Behavioral Neurology

Presentation(s) (-)

Poster/Presentation
Number 207

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Jeffrey J. Sevigny, MD (F. Hoffmann-La Roche) PRESENTER	Dr. Sevigny has received personal compensation for serving as an employee of Rapport Therapeutics.
Joyce Suhy, PhD (BioClinica)	Dr. Suhy has nothing to disclose.
Ping Chiao, MD (Biogen Idec)	No disclosure on file
Gregory Klein, PhD (Roche)	Dr. Klein has received personal compensation for serving as an employee of Roche. Dr. Klein has received stock or an ownership interest from Roche.
Joonmi Oh, PhD (Synarc Inc)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Mitchell S. Elkind, MD, MS, F�鶹��ýӳ��	Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy.

�鶹��ýӳ��